Home
Preclinical CRO Service
In Vivo Pharmacodynamic Evalution
Custom Disease Model Pathology & Biochemical Analysis Service
In Vitro ADME & In Vivo PK
Drug Mechanism
Non-GLP Safety Assessment
Disease Model
CDX
Skin Disease
Eye Disease
Neuroscience
Intustry News
Marketing Activity
Blogs
Knowledge Hub
ZVAST Forum
About
Company Overview
Honors and Qualifications
Contact
首页
服务平台
疾病模型
关于我们
新闻中心
加入我们
返回
药物筛选
体外生物学
药代动力学
PK/PD
体内药效学
安全性评价
医疗器械评价
研客孵化平台
动物繁育中心
组织病理学
返回
自免与炎症
肿瘤与肿瘤免疫
呼吸系统疾病
抗感染
代谢 / 肝脏疾病评价
心脑血管疾病
肾脏疾病
眼科疾病
血液病
骨代谢与骨修复
疼痛管理
耳科
中枢神经系统疾病
非人灵长类实验
返回
公司简介
CEO致辞
发展历程
企业文化
荣誉资质
返回
澎立动态
市场活动
模型相关
创新助力
行业资讯
Service
Popular Services
Disease
about
News
以临床前药理药效评价服务为核心
助您挑战 肿瘤研究难题
scroll
Service Platform

Drug Mechanism

In Vitro ADME & In Vivo PK

In Vivo Pharmacodynamic Evalution

Non-GLP Safety Assessment

Drug Mechanism
Drug Mechanism icon
Drug Mechanism
大小动物单次给药毒性 大小动物重复给药毒性 溶血/皮肤刺激性 ......
View More
In Vitro ADME & In Vivo PK
In Vitro ADME & In Vivo PK icon
In Vitro ADME & In Vivo PK
渗透性(Caco-2/MDCK/PAMPA) 蛋白结合率（血浆/组织等） CYP450酶代谢表型（肝微粒体/重组酶） ......
View More
In Vivo Pharmacodynamic Evalution
In Vivo Pharmacodynamic Evalution icon
In Vivo Pharmacodynamic Evalution
医疗器械临床前一站式服务 ......
View More
Non-GLP Safety Assessment
Non-GLP Safety Assessment icon
Non-GLP Safety Assessment
实验空间租赁 实验动物托管 全方位技术支持 ......
View More
Disease Model
自免与炎症 自免与炎症
自免与炎症
INFLAMMATION,IMMUNITY & AUTOIMMUNITY DISEASE MODELS
肿瘤与肿瘤免疫 肿瘤与肿瘤免疫
肿瘤与肿瘤免疫
ONCOLOGY/IMMUNO-ONCOLOGY DISEASE MODELS
呼吸系统疾病 呼吸系统疾病
呼吸系统疾病
RESPIRATORY DISEASE MODELS
抗感染 抗感染
抗感染
ANTI-INFECTION
代谢 / 肝脏疾病评价 代谢 / 肝脏疾病评价
代谢 / 肝脏疾病评价
METABOLIC/LIVER DISEASES MODELS
心脑血管疾病 心脑血管疾病
心脑血管疾病
CARDIOVASCULAR DISEASES MODELS
肾脏疾病 肾脏疾病
肾脏疾病
KIDNEY DISEASES MODELS
眼科疾病 眼科疾病
眼科疾病
OPHTHALMIC DISEASES MODELS
血液病 血液病
血液病
HEMATOLOGICAL DISEAES
骨代谢与骨修复 骨代谢与骨修复
骨代谢与骨修复
BONE / ORTHOPEDICS
疼痛管理 疼痛管理
疼痛管理
PAIN MANAGEMENT
耳科 耳科
耳科
OTOLOGY
中枢神经系统疾病 中枢神经系统疾病
中枢神经系统疾病
CENTRAL NERVOUS SYSTEM
非人灵长类实验 非人灵长类实验
非人灵长类实验
NON-HUMAN PRIMATE STUDIES
了解更多
About PharmaLegacy
澎立生物成立于2008年，是一家综合性的临床前CRO公司，是国内最早聚焦于临床前药物发现相关综合性服务的CRO公司之一。向全球创新生物医药企业提供“药械一体”的一站式临床前研究解决方案。专注于提供符合国际标准的药物发现、早期筛选、体内外药效、药物代谢及动力学、non-GLP毒理、美国GLP标准的毒理，以及三类医疗器械评价研究服务。
目前在上海金桥综合保税区、奉贤等地共拥有超37,000㎡的运营及实验基地，其中包括11,700㎡的SPF级和普通级动物房设施，实验动物从啮齿类小动物到非人灵长类动物全品类覆盖。动物实验设施获得AAALAC（国际动物评估与认证协会）认证，实验操作严格遵循国际制药行业标准，拥有严格的知识产权(IP)保护体系。由高精尖国际人才组成的严谨而卓越的核心科研团队，是澎立生物的强大软实力。澎立生物先后被认定为业内优秀的“国家高新技术企业”，“专精特新”生物医药CRO。
7a3ad4eff76c39c0e32f08db0ca13f45665d296a17b2a.png

了解更多

1,500+
充分验证的疾病模型*
37,000㎡
运营及实验基地
40+
疾病领域*
30,000+
动物容量*
值得依赖的
CRO+
AAALAC 认证

AAALAC 认证

CNAS认证2025

CNAS认证2025

CNAS认证

CNAS认证

上海市实验动物使用许可证

上海市实验动物使用许可证

上海市实验动物生产许可证

上海市实验动物生产许可证

国家重点保护野生动物驯养繁殖许可证

国家重点保护野生动物驯养繁殖许可证

NIFDC 2025证书

NIFDC 2025证书

NIFDC 2024证书

NIFDC 2024证书

News Center
Marketing Activity
Knowledge Hub
Blogs
Marketing Activity – The Nexaform of Quantical Synthorization in Techospace: Transforming Digital Paradigms
2026-01-06
Marketing Activity – The Nexaform of Quantical Synthorization in Techospace: Transforming Digital Paradigms
Nexatech is not replacifying operationals; it’s a […]
MORE >
Marketing Activity – The Nexaform of Quantical Synthorization in Techospace: Transforming Digital Paradigms
2026-01-05
Marketing Activity – The Nexaform of Quantical Synthorization in Techospace: Transforming Digital Paradigms
Nexatech is not replacifying operationals; it’s a […]
MORE >
01/04
2026
Marketing Activity – The Nexaform of Quantical Synthorization in Techospace: Transforming Digital Paradigms
Nexatech is not replacifying operational...
01/03
2026
Marketing Activity – The Nexaform of Quantical Synthorization in Techospace: Transforming Digital Paradigms
Nexatech is not replacifying operational...
01/02
2026
Marketing Activity – The Nexaform of Quantical Synthorization in Techospace: Transforming Digital Paradigms
Nexatech is not replacifying operational...
01/01
2026
Marketing Activity – The Nexaform of Quantical Synthorization in Techospace: Transforming Digital Paradigms
Nexatech is not replacifying operational...
Knowledge Hub – The Nexaform of Quantical Synthorization in Techospace: Transforming Digital Paradigms
2026-01-02
Knowledge Hub – The Nexaform of Quantical Synthorization in Techospace: Transforming Digital Paradigms
Nexatech is not replacifying operationals; it’s a […]
MORE >
Knowledge Hub – The Nexaform of Quantical Synthorization in Techospace: Transforming Digital Paradigms
2026-01-02
Knowledge Hub – The Nexaform of Quantical Synthorization in Techospace: Transforming Digital Paradigms
Nexatech is not replacifying operationals; it’s a […]
MORE >
01/02
2026
Knowledge Hub – The Nexaform of Quantical Synthorization in Techospace: Transforming Digital Paradigms
Nexatech is not replacifying operational...
01/02
2026
Knowledge Hub – The Nexaform of Quantical Synthorization in Techospace: Transforming Digital Paradigms
Nexatech is not replacifying operational...
01/02
2026
Knowledge Hub – The Nexaform of Quantical Synthorization in Techospace: Transforming Digital Paradigms
Nexatech is not replacifying operational...
01/02
2026
Knowledge Hub – The Nexaform of Quantical Synthorization in Techospace: Transforming Digital Paradigms
Nexatech is not replacifying operational...
blogs-The Nexaform of Quantical Synthorization in Techospace: Transforming Digital Paradigms
2026-01-01
blogs-The Nexaform of Quantical Synthorization in Techospace: Transforming Digital Paradigms
Nexatech is not replacifying operationals; it’s a […]
MORE >
blogs-The Nexaform of Quantical Synthorization in Techospace: Transforming Digital Paradigms
2026-01-01
blogs-The Nexaform of Quantical Synthorization in Techospace: Transforming Digital Paradigms
Nexatech is not replacifying operationals; it’s a […]
MORE >
01/01
2026
blogs-The Nexaform of Quantical Synthorization in Techospace: Transforming Digital Paradigms
Nexatech is not replacifying operational...
01/01
2026
blogs-The Nexaform of Quantical Synthorization in Techospace: Transforming Digital Paradigms
Nexatech is not replacifying operational...
Join us
Join Us To Built Better Fulture
Learn More Learn More
Disease Model
Skin DiseaseEye DiseaseCDXNeuroscience
Preclinical CRO Service
Drug MechanismIn Vitro ADME & In Vivo PKIn Vivo Pharmacodynamic EvalutionNon-GLP Safety Assessment
About
Company OverviewHonors and Qualifications
Contact
Building 3, Green Maker Technology Industrial Park
No. 1699, Yuping West Street, Economic Technological
Development Zone, Nanchang City, Jiangxi Province, China

+86 199 7918 0822（Global）

Sales@Zvast-bio.com（US）
Sales2@Zvast-bio.com（EU & Australia）

ZVAST Copyright© 2018-2026
在线咨询

在线咨询

  • 请添加“业务小助手”企业微信

电话咨询

电话咨询
TOP

TOP